Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

1.03
Delayed Data
As of May 05
 -0.10 / -8.85%
Today’s Change
0.25
Today|||52-Week Range
13.64
-65.78%
Year-to-Date

Today’s Trading

Previous close1.13
Today’s open1.04
Day’s range0.98 - 1.12
Volume2,234,811
Average volume (3 months)1,532,087
Market cap$15.4M
Dividend yield--
Data as of 05/05/2016

Growth & Valuation

Earnings growth (last year)+25.74%
Earnings growth (this year)+41.41%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-55.86%
P/E ratioNM
Price/Sales57.75
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...0.000.00%
IMNPImmune Pharmaceutica...0.000.00%
ACSTAcasti Pharma Inc0.000.00%
RTTRRitter Pharmaceutica...0.000.00%
Data as of 05/05/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$990.0K
Annual profit (last year)-$33.5M
Net profit margin-3,378.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs